ID   vFOP4-1
AC   CVCL_W553
SY   CiRA00041; HPS0376
DR   RCB; HPS0376
DR   SKIP; SKIP000339
DR   SKIP; SKIP000635
DR   Wikidata; Q54993078
RX   PubMed=24321451;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Miscellaneous: Assignment of vFOP4-1 to CiRA00041 from personal communication from CiRA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W554 ! vFOP4-3
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
RX   PubMed=24321451; DOI=10.1186/1750-1172-8-190; PMCID=PMC3892046;
RA   Matsumoto Y., Hayashi Y., Schlieve C.R., Ikeya M., Kim H.,
RA   Nguyen T.D., Sami S., Baba S., Barruet E., Nasu A., Asaka I.,
RA   Otsuka T., Yamanaka S., Conklin B.R., Toguchida J., Hsiao E.C.;
RT   "Induced pluripotent stem cells from patients with human
RT   fibrodysplasia ossificans progressiva show increased mineralization
RT   and cartilage formation.";
RL   Orphanet J. Rare Dis. 8:190.1-190.14(2013).
//